East Coast and West Coast VCs have easy access to the most dynamic technology and life science markets in the country. But Midwest VCs have access to smaller deals and promising companies that oftentimes fly under the radar of the big coastal investors.
Some have the best of both worlds.
Athenian Venture Partners, for one, has offices in Boston and San Diego, but its headquarters are tucked away in Athens, Ohio, the home of Ohio University. The firm manages four funds totaling about $105 million and splits its investments between promising information technology and healthcare companies, according to partner David Scholl. Its portfolio includes companies across the country, from LygoCyte Pharmaceuticals in Montana to Micromet (acquired by Amgen in January) in Maryland to Verus Pharmaceuticals in San Diego.
To read the original article: Midwest IT/life science VC: We see deals that other VCs fly right over | MedCity News
